Navigation Links
Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes

human exposure at the MRHD of 100 mg/day based on AUC comparisons). At higher doses, nondose-related increased resorptions in females were observed (approximately 25 and 100 times human exposure at the MRHD based on AUC comparison). 14 CLINICAL STUDIES There were 2316 patients with type 2 diabetes randomized in four double-blind, placebo-controlled clinical safety and efficacy studies conducted to evaluate the effects of sitagliptin on glycemic control. In these studies, the mean age of patients was 54.8 years, and 62% of patients were white, 18% were Hispanic, 6% were black, 9% were Asian, and 4% were of other racial groups. In patients with type 2 diabetes, treatment with JANUVIA produced clinically significant improvements in hemoglobin A1C, fasting plasma glucose (FPG) and 2-hour post-prandial glucose (PPG) compared to placebo. 14.1 Monotherapy A total of 1262 patients with type 2 diabetes participated in two double-blind, placebo-controlled studies, one of 18-week and another of 24-week duration, to evaluate the efficacy and safety of JANUVIA monotherapy. In both monotherapy studies, patients currently on an antihyperglycemic agent discontinued the agent, and underwent a diet, exercise, and drug wash-out period of about 7 weeks. Patients with inadequate glycemic control (A1C 7% to 10%) after the wash-out period were randomized after completing a 2-week single-blind placebo run-in period; patients not currently on antihyperglycemic agents (off therapy for at least 8 weeks) with inadequate glycemic control (A1C 7% to 10%) were randomized after completing the 2-week single-blind placebo run-in period. In the 18-week study, 521 patients were randomized to placebo, JANUVIA 100 mg, or JANUVIA 200 mg, and in the 24-week study 741 patients were randomized to placebo, JANUVIA 100 mg, or JANUVIA 200 mg. Patients who failed to meet specific glycemic goals during the studies were treated with metformin rescue, added
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
2. Pilot Phase 3 Results of NovaCardias KW-3902 for Acute Congestive Heart Failure Presented at Late-Breaking Session of Heart Failure Congress 2007
3. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
4. Bentley Late Breaking Abstract Accepted for Poster Presentation at American Diabetes Association Scientific Sessions
5. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
6. Everest Data on Short- and Long-Term Use of Otsukas Investigational Novel Treatment, Tolvaptan, Published in Journal of the American Medical Association and Featured in ACCs Late Breaking Clinical Trials
7. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
8. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
9. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
10. Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
11. New Anti-Rejection Medication 6-Month Results for Heart Transplant Recipients to Be Released at International Heart and Lung Transplant Meeting
Post Your Comments:
(Date:8/29/2014)... , Aug. 29, 2014  BC Technical, the ... acquired Polaris Medical Imaging, a leader in sales, service ... strategic acquisition allows BC Technical to continue to expand ... within MR and CT modalities. "We ... said Mark Alvarez , president and CEO of ...
(Date:8/29/2014)... Does your doctor know what you,re smoking?  Chances ... marijuana to the over 112,000 currently registered patients under ... the other roughly 20,300+ active physicians listed with the Colorado ... – even though a poll in February 2014 showed 51% ... tried it. "With marijuana legalization underway, every ...
(Date:8/29/2014)... WASHINGTON , Aug. 29, 2014 Diseases ... a generation ago are returning. Measles was declared ... cases in 2014 as of August 15—the highest incidence ... public health department declared whooping cough a problem ... children are getting sick and dying from these preventable ...
Breaking Medicine Technology:BC Technical Acquires Polaris Medical Imaging 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3
... (Nasdaq: THOR ), a world leader in ... restore failing hearts, said today that it will be ... On Wednesday, September 22, Thoratec will participate in the ... vice president and chief financial officer, will provide an ...
... 16 Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ... Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs ... data do not adequately demonstrate that the potential benefits ... in a population of overweight and obese individuals to ...
Cached Medicine Technology:Thoratec to Present at Upcoming Investor Conferences 2Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting 2Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting 3Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting 4
(Date:8/30/2014)... 2014 RB SEO Services, a well-recognized ... for small businesses. , RBSEO Services knows this very ... search engine optimization service. So, the company has introduced ... account. , On being asked about the service, ... low cost SEO service because many small businesses expressed ...
(Date:8/30/2014)... 30, 2014 After offering hyperbaric ... for the past several years, Dr. Roy Schmidt ... have announced a scholarship program for veterans who ... a meeting held this summer to discuss veterans’ ... reporters have shed light on the large number ...
(Date:8/30/2014)... Richmond, VA (PRWEB) August 30, 2014 Seniors ... several articles recently that focus on Alzheimer’s Disease, Dementia, ... recently revealed to the public of being diagnosed with the ... his latest movie, “I’ll Be Me”. The movie, out ... life while focusing on his diagnosis of the disease – ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 Continuing to ... Dermatology is expanding with the addition of a new ... Hammond who has provided leading-edge skin care in Grand ... Dermatology. , “As a doctor, my passion is ... Through partnering with Forefront Dermatology, I’m better able to ...
(Date:8/30/2014)... Phoenix, AZ (PRWEB) August 30, 2014 ... experienced personal injury attorneys located throughout Arizona is pleased ... settlement. This is one specific example among many cases ... that clients are able to retain a greater portion ... case after case that providing a positive solution for ...
Breaking Medicine News(10 mins):Health News:RBSEO Services Introduces Low Cost SEO Service for Small Businesses 2Health News:Tennessee Hyperbaric Center Offering HBOT Scholarships to Veterans 2Health News:Alzheimer’s Disease and Dementia Focus on Retirement Website SeniorsGuideOnline.com 2Health News:Expanding Care at the Forefront of Dermatology 2Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $67,100 On A Settlement Of $610,000 2
... Testing Rates Are StagnantAmidst Call for Stepped Up Focus ... Spending and the Public Believes Greater Efforts on Prevention ... a year after the Centers for Disease Control and ... and announced that there were 40 percent more new ...
... April 28, 2009 Peripheral arterial disease (PAD) of the legs, ... to the legs is reduced, affects eight million people in the ... the ability to walk and exercise, it may place patients at ... having a heart attack or stroke. Coronary artery disease (CAD) is ...
... in during a tournament directly affects their risk for medical withdrawal ... May/June 2009 issue of Sports Health: A Multidisciplinary Approach. , ... ... of matches junior tennis players compete in during a tournament directly ...
... success in tracking medications, reducing workload, , , TUESDAY, April ... it easier for medical staff to monitor patients who ... study reports. , People taking anticoagulants must be closely ... clots and hemorrhage, which can be fatal. But, ...
... also have diagnosed or undiagnosed obstructive sleep apnea prior ... April 28, 2009, at the American Academy of Neurology ... professor and chair of the Department of Emergency Medicine ... of Neurosurgery, reported the findings at AAN, along with ...
... was issued today by the Seva Foundation: WHAT: Leading ... "Seeing Women: Taking on Gender Inequities in Global Blindness and ... event will explore the links between gender and blindness, poverty, ... gaps. The goal is to build a strong base of ...
Cached Medicine News:Health News:Less Than a Year After CDC Announced the U.S. HIV Epidemic Is Much Larger Than Previously Thought, Public's Sense of Urgency Is Down, Even Among Some Higher Risk Groups 2Health News:Less Than a Year After CDC Announced the U.S. HIV Epidemic Is Much Larger Than Previously Thought, Public's Sense of Urgency Is Down, Even Among Some Higher Risk Groups 3Health News:Less Than a Year After CDC Announced the U.S. HIV Epidemic Is Much Larger Than Previously Thought, Public's Sense of Urgency Is Down, Even Among Some Higher Risk Groups 4Health News:Arterial disease of the leg frequently overlooked in patients with heart disease 2Health News:Number of Matches Played Determines Teen Tennis Players' Risk for Medical Withdrawal 2Health News:Number of Matches Played Determines Teen Tennis Players' Risk for Medical Withdrawal 3Health News:Automated Calls May Help Doctors Monitor Patients 2Health News:Poor sleep quality leads to poorer prognosis after stroke 2Health News:A Call to Action: NGOs Working in Blindness Prevention and Treatment Convene Special Forum to Address Gender and Eye Health 2
... most comprehensive family of lightweight standard ... incision, Glaucoma filtration, and Vitreoretinal uses. ... with minimal tissue trauma and minimal ... are available in 18, 20, and ...
... Centuries of German Craftsmanship have ... in the world. Ocutek now ... Only holders of the coveted ... eight-year apprenticeship, are qualified to ...
... Centuries of German Craftsmanship ... instrumentation in the world. Ocutek ... you! Only holders of the ... and eight-year apprenticeship, are qualified ...
... German Craftsmanship have produced the ... world. Ocutek now makes them ... of the coveted Meisterbrief certificate, ... are qualified to become Ocutek ...
Medicine Products: